Experimental group:Refer to the National Health Office Medical Letter (2020) 77 document "Diagnosis and treatment plan for the novel coronavirus disease (trial version 5)" general treatment plan. Base

2 trials

Sponsors

Affiliated Hospital of traditional Chinese and Western Medicine Nanjing University of Chinese Medicine

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Early Phase 1

Study for the Effectiveness and Safety of Yi-Qi Hua-shi Jie-Du-Fang in the Treatment of the Novel Coronavirus Pneumonia (COVID-19)

Active, not recruitingITMCTR2000003080

Affiliated Hospital of traditional Chinese and Western Medicine Nanjing University of Chinese MedicineNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-02-26Updated: 2023-02-20

Study for the Effectiveness and Safety of Yi-Qi Hua-shi Jie-Du-Fang in the Treatment of the Novel Coronavirus Pneumonia (COVID-19)

Active, not recruitingChiCTR2000030479

Affiliated Hospital of traditional Chinese and Western Medicine Nanjing University of Chinese MedicineNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-02-26Updated: 2020-03-09